High-dose spironolactone doesn’t improve on usual care for acute HF
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- The addition of spironolactone (Aldactone) to usual care for 96 h in patients with acute heart failure (HF) does not improve any endpoints vs outcomes with usual care.
- Blood and urine biomarkers, weight, symptoms, and congestion levels were similar between the groups.